{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:02:04Z","timestamp":1777561324418,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00428-025-04046-0","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T18:42:51Z","timestamp":1738867371000},"page":"535-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perforin-2 is overexpressed in Kikuchi-Fujimoto disease"],"prefix":"10.1007","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-9735","authenticated-orcid":false,"given":"Kirill A.","family":"Lyapichev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narittee","family":"Sukswai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siok Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwa S.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Amr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noula D.","family":"Shembade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"4","key":"4046_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00125480-200307000-00003","volume":"10","author":"M Onciu","year":"2003","unstructured":"Onciu M, Medeiros LJ (2003) Kikuchi-Fujimoto lymphadenitis. Adv Anat Pathol 10(4):204\u2013211","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"4046_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00000478-199403000-00001","volume":"18","author":"WY Tsang","year":"1994","unstructured":"Tsang WY, Chan JK, Ng CS (1994) Kikuchi\u2019s lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol 18(3):219\u2013231","journal-title":"Am J Surg Pathol"},{"key":"4046_CR3","unstructured":"Kikuchi M (1972) Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. Acta Hematol 35:379\u201380"},{"issue":"7","key":"4046_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/00000478-199507000-00008","volume":"19","author":"TT Kuo","year":"1995","unstructured":"Kuo TT (1995) Kikuchi\u2019s disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol 19(7):798\u2013809","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4046_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/his.14050","volume":"77","author":"N Sukswai","year":"2020","unstructured":"Sukswai N et al (2020) Immunopathology of Kikuchi-Fujimoto disease: a reappraisal using novel immunohistochemistry markers. Histopathology 77(2):262\u2013274","journal-title":"Histopathology"},{"issue":"1","key":"4046_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaad.2008.03.012","volume":"59","author":"AR Atwater","year":"2008","unstructured":"Atwater AR, Longley BJ, Aughenbaugh WD (2008) Kikuchi\u2019s disease: case report and systematic review of cutaneous and histopathologic presentations. J Am Acad Dermatol 59(1):130\u2013136","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4046_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1542\/peds.2005-0088","volume":"115","author":"JY Chung","year":"2005","unstructured":"Chung JY et al (2005) Detection of the Bartonella henselae gene sequence in lymph nodes of children with Kikuchi\u2019s disease. Pediatrics 115(4):1112","journal-title":"Pediatrics"},{"issue":"1","key":"4046_CR8","first-page":"51","volume":"17","author":"K Charalabopoulos","year":"2003","unstructured":"Charalabopoulos K et al (2003) Brucella melitensis infection stimulates an immune response leading to Kikuchi-Fujimoto disease. In Vivo 17(1):51\u201353","journal-title":"In Vivo"},{"issue":"5\u20136","key":"4046_CR9","first-page":"222","volume":"41","author":"J Heikens","year":"1992","unstructured":"Heikens J et al (1992) Kikuchi\u2019s lymphadenitis: report of a Yersinia enterocolitica-associated case and an overview of aetiology and clinical outcome. Neth J Med 41(5\u20136):222\u2013228","journal-title":"Neth J Med"},{"issue":"6","key":"4046_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2559.1983.tb02299.x","volume":"7","author":"AC Feller","year":"1983","unstructured":"Feller AC et al (1983) Immunohistology and aetiology of histiocytic necrotizing lymphadenitis report of three instructive cases. Histopathology 7(6):825\u2013839","journal-title":"Histopathology"},{"issue":"3","key":"4046_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00432400","volume":"376","author":"M Kikuchi","year":"1977","unstructured":"Kikuchi M, Yoshizumi T, Nakamura H (1977) Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch A Pathol Anat Histol 376(3):247\u2013253","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"4","key":"4046_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00043426-200105000-00012","volume":"23","author":"JL Stephan","year":"2001","unstructured":"Stephan JL et al (2001) Epstein-Barr virus-associated Kikuchi disease in two children. J Pediatr Hematol Oncol 23(4):240\u2013243","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2 Pt 2","key":"4046_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0190-9622(97)80413-6","volume":"36","author":"A Yen","year":"1997","unstructured":"Yen A et al (1997) EBV-associated Kikuchi\u2019s histiocytic necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol 36(2 Pt 2):342\u2013346","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4046_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0163-4453(92)93729-A","volume":"25","author":"EM Rabadao","year":"1992","unstructured":"Rabadao EM et al (1992) Kikuchi\u2019s disease associated with Epstein-Barr virus infection. J Infect 25(1):109\u2013110","journal-title":"J Infect"},{"issue":"3","key":"4046_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1684-1182(10)60040-0","volume":"43","author":"HY Lee","year":"2010","unstructured":"Lee HY et al (2010) Primary Epstein-Barr virus infection associated with Kikuchi\u2019s disease and hemophagocytic lymphohistiocytosis: a case report and review of the literature. J Microbiol Immunol Infect 43(3):253\u2013257","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"4046_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1309\/1A6Y-YCKP-5AVF-QTYR","volume":"113","author":"CF Chiu","year":"2000","unstructured":"Chiu CF et al (2000) Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol 113(6):774\u2013781","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"4046_CR17","first-page":"362","volume":"1","author":"SD Hudnall","year":"2008","unstructured":"Hudnall SD et al (2008) Detection of human herpesvirus DNA in Kikuchi-Fujimoto disease and reactive lymphoid hyperplasia. Int J Clin Exp Pathol 1(4):362\u2013368","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4046_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00019606-200603000-00008","volume":"15","author":"N Maeda","year":"2006","unstructured":"Maeda N et al (2006) Quantitative analysis of herpesvirus load in the lymph nodes of patients with histiocytic necrotizing lymphadenitis using a real-time PCR assay. Diagn Mol Pathol 15(1):49\u201355","journal-title":"Diagn Mol Pathol"},{"issue":"3","key":"4046_CR19","first-page":"265","volume":"5","author":"A Hoffmann","year":"1991","unstructured":"Hoffmann A et al (1991) Active human herpesvirus-6 (HHV-6) infection associated with Kikuchi-Fujimoto disease and systemic lupus erythematosus (SLE). In Vivo 5(3):265\u2013269","journal-title":"In Vivo"},{"issue":"3C","key":"4046_CR20","first-page":"2155","volume":"21","author":"GR Krueger","year":"2001","unstructured":"Krueger GR et al (2001) Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin\u2019s and Kikuchi\u2019s diseases and their relation to proliferation and apoptosis. Anticancer Res 21(3C):2155\u20132161","journal-title":"Anticancer Res"},{"issue":"3","key":"4046_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/01.SMJ.0000054420.01333.B0","volume":"96","author":"DC Dominguez","year":"2003","unstructured":"Dominguez DC, Torres ML, Antony S (2003) Is human herpesvirus 6 linked to kikuchi-fujimoto disease? The importance of consistent molecular and serologic analysis. South Med J 96(3):226\u2013233","journal-title":"South Med J"},{"issue":"10","key":"4046_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0046-8177(98)90419-1","volume":"29","author":"J Huh","year":"1998","unstructured":"Huh J et al (1998) Kaposi\u2019s sarcoma-associated herpesvirus in Kikuchi\u2019s disease. Hum Pathol 29(10):1091\u20131096","journal-title":"Hum Pathol"},{"issue":"7","key":"4046_CR23","first-page":"391","volume":"98","author":"VK Harris","year":"2000","unstructured":"Harris VK et al (2000) Unusual association of Kikuchi\u2019s disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc 98(7):391\u2013393","journal-title":"J Indian Med Assoc"},{"issue":"1","key":"4046_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/096120339100100107","volume":"1","author":"O Meyer","year":"1991","unstructured":"Meyer O et al (1991) Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi\u2019s disease) associated with systemic lupus erythematosus. Lupus 1(1):37\u201341","journal-title":"Lupus"},{"issue":"4","key":"4046_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1046\/j.1365-2141.1997.d01-2099.x","volume":"96","author":"Y Yufu","year":"1997","unstructured":"Yufu Y et al (1997) Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi\u2019s disease). Br J Haematol 96(4):868\u2013871","journal-title":"Br J Haematol"},{"key":"4046_CR26","doi-asserted-by":"crossref","unstructured":"Vassallo J, Coelho Filho JC, Amaral VG (2002) Histiocytic necrotizing lymphadenitis (Kikuchi lymphadenitis) in an HIV-positive patient. Rev Inst Med Trop Sao Paulo 44(5):265\u2013268.","DOI":"10.1590\/S0036-46652002000500006"},{"issue":"4","key":"4046_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1046\/j.1365-2133.1997.d01-1246.x","volume":"136","author":"V Bataille","year":"1997","unstructured":"Bataille V et al (1997) Kikuchi disease (histiocytic necrotizing lymphadenitis) in association with HTLV1. Br J Dermatol 136(4):610\u2013612","journal-title":"Br J Dermatol"},{"issue":"5","key":"4046_CR28","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1111\/bjh.17292","volume":"192","author":"L Stimson","year":"2021","unstructured":"Stimson L et al (2021) COVID-19 associated Kikuchi-Fujimoto disease. Br J Haematol 192(5):e124\u2013e126","journal-title":"Br J Haematol"},{"issue":"3","key":"4046_CR29","first-page":"222","volume":"41","author":"A Rammohan","year":"2012","unstructured":"Rammohan A et al (2012) Kikuchi-Fujimoto disease: a sheep in wolf\u2019s clothing. J Otolaryngol Head Neck Surg 41(3):222\u2013226","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"6","key":"4046_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1309\/N4E2-78V9-QTFH-X4FF","volume":"113","author":"SD Hudnall","year":"2000","unstructured":"Hudnall SD (2000) Kikuchi-Fujimoto disease. Is Epstein-Barr virus the culprit? Am J Clin Pathol 113(6):761\u2013764","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"4046_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.humpath.2012.05.016","volume":"44","author":"FG Rosado","year":"2013","unstructured":"Rosado FG et al (2013) Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8. Hum Pathol 44(2):255\u2013259","journal-title":"Hum Pathol"},{"issue":"8","key":"4046_CR32","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","volume":"107","author":"SA Keller","year":"2006","unstructured":"Keller SA et al (2006) NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107(8):3295\u20133302","journal-title":"Blood"},{"issue":"2","key":"4046_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.07.030","volume":"345","author":"SA Read","year":"2014","unstructured":"Read SA, Douglas MW (2014) Virus induced inflammation and cancer development. Cancer Lett 345(2):174\u2013181","journal-title":"Cancer Lett"},{"key":"4046_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.smim.2017.09.006","volume":"32","author":"J Chen","year":"2017","unstructured":"Chen J, Pitmon E, Wang K (2017) Microbiome, inflammation and colorectal cancer. Semin Immunol 32:43\u201353","journal-title":"Semin Immunol"},{"issue":"4","key":"4046_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3109\/10428194.2011.627482","volume":"53","author":"P Szturz","year":"2012","unstructured":"Szturz P et al (2012) Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leuk Lymphoma 53(4):743\u2013745","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4046_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2141.1996.d01-1964.x","volume":"95","author":"M Kubota","year":"1996","unstructured":"Kubota M et al (1996) Elevated serum interferon gamma and interleukin-6 in patients with necrotizing lymphadenitis (Kikuchi\u2019s disease). Br J Haematol 95(4):613\u2013615","journal-title":"Br J Haematol"},{"issue":"5","key":"4046_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2559.1998.00532.x","volume":"33","author":"K Ohshima","year":"1998","unstructured":"Ohshima K et al (1998) Perforin and Fas pathways of cytotoxic T-cells in histiocytic necrotizing lymphadenitis. Histopathology 33(5):471\u2013478","journal-title":"Histopathology"},{"issue":"1","key":"4046_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1309\/YF081L4TKYWVYVPQ","volume":"122","author":"X Bosch","year":"2004","unstructured":"Bosch X et al (2004) Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol 122(1):141\u2013152","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4046_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1189\/jlb.4MR1114-523RR","volume":"98","author":"R McCormack","year":"2015","unstructured":"McCormack R, Podack ER (2015) Perforin-2\/Mpeg1 and other pore-forming proteins throughout evolution. J Leukoc Biol 98(5):761\u2013768","journal-title":"J Leukoc Biol"},{"key":"4046_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7554\/eLife.06508","volume":"4","author":"RM McCormack","year":"2015","unstructured":"McCormack RM et al (2015) Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. Elife 4:4","journal-title":"Elife"},{"issue":"2","key":"4046_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000366103","volume":"7","author":"EL Benard","year":"2015","unstructured":"Benard EL et al (2015) Macrophage-expressed perforins mpeg1 and mpeg1.2 have an anti-bacterial function in zebrafish. J Innate Immun 7(2):136\u2013152","journal-title":"J Innate Immun"},{"issue":"8","key":"4046_CR42","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.4049\/jimmunol.1901013","volume":"204","author":"R McCormack","year":"2020","unstructured":"McCormack R et al (2020) An essential role for Perforin-2 in type I IFN signaling. J Immunol 204(8):2242\u20132256","journal-title":"J Immunol"},{"issue":"8","key":"4046_CR43","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1128\/IAI.00497-13","volume":"81","author":"KA Fields","year":"2013","unstructured":"Fields KA et al (2013) Perforin-2 restricts growth of chlamydia trachomatis in macrophages. Infect Immun 81(8):3045\u20133054","journal-title":"Infect Immun"},{"key":"4046_CR44","doi-asserted-by":"crossref","unstructured":"McCormack RM et al (2017) MPEG1\/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. JCI Insight 2(8):e89635","DOI":"10.1172\/jci.insight.89635"},{"issue":"7","key":"4046_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007883","volume":"15","author":"J Hyun","year":"2019","unstructured":"Hyun J et al (2019) HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in kupffer and myeloid cells. PLoS Pathog 15(7):e1007883","journal-title":"PLoS Pathog"},{"issue":"3","key":"4046_CR46","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1128\/JVI.02007-13","volume":"88","author":"J Brownell","year":"2014","unstructured":"Brownell J et al (2014) Direct, interferon-independent activation of the CXCL10 promoter by NF-kappaB and interferon regulatory factor 3 during hepatitis C virus infection. J Virol 88(3):1582\u20131590","journal-title":"J Virol"},{"issue":"1","key":"4046_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2011-06-363994","volume":"119","author":"M Chen","year":"2012","unstructured":"Chen M, Felix K, Wang J (2012) Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood 119(1):127\u2013136","journal-title":"Blood"},{"issue":"1","key":"4046_CR48","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1038\/s41467-022-32757-4","volume":"13","author":"F Jiao","year":"2022","unstructured":"Jiao F et al (2022) Perforin-2 clockwise hand-over-hand pre-pore to pore transition mechanism. Nat Commun 13(1):5039","journal-title":"Nat Commun"},{"key":"4046_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2148-12-59","volume":"12","author":"ME D\u2019Angelo","year":"2012","unstructured":"D\u2019Angelo ME et al (2012) Perforin evolved from a gene duplication of MPEG1, followed by a complex pattern of gene gain and loss within Euteleostomi. BMC Evol Biol 12:59","journal-title":"BMC Evol Biol"},{"key":"4046_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.581906","volume":"11","author":"C Bayly-Jones","year":"2020","unstructured":"Bayly-Jones C et al (2020) Ancient but not forgotten: new insights into MPEG1, a macrophage perforin-like immune effector. Front Immunol 11:581906","journal-title":"Front Immunol"},{"issue":"10","key":"4046_CR51","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1440-1827.1995.tb03389.x","volume":"45","author":"Q Liu","year":"1995","unstructured":"Liu Q et al (1995) Apoptosis in histiocytic necrotizing lymphadenitis. Pathol Int 45(10):729\u2013734","journal-title":"Pathol Int"},{"issue":"2","key":"4046_CR52","first-page":"97","volume":"61","author":"K Ohshima","year":"1991","unstructured":"Ohshima K et al (1991) Proliferating cells in histiocytic necrotizing lymphadenitis. Virchows Arch B Cell Pathol Incl Mol Pathol 61(2):97\u2013100","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"2","key":"4046_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1440-1827.2007.02196.x","volume":"58","author":"Y Nomura","year":"2008","unstructured":"Nomura Y et al (2008) Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining. Pathol Int 58(2):98\u2013103","journal-title":"Pathol Int"},{"issue":"6","key":"4046_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1346-8138.1999.tb03494.x","volume":"26","author":"H Ura","year":"1999","unstructured":"Ura H et al (1999) Histiocytic necrotizing lymphadenitis (Kikuchi\u2019s disease): the necrotic appearance of the lymph node cells is caused by apoptosis. J Dermatol 26(6):385\u2013389","journal-title":"J Dermatol"},{"issue":"6651","key":"4046_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.adg8802","volume":"380","author":"P Rodriguez-Silvestre","year":"2023","unstructured":"Rodriguez-Silvestre P et al (2023) Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells. Science 380(6651):1258\u20131265","journal-title":"Science"},{"issue":"6651","key":"4046_CR56","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1126\/science.adi5711","volume":"380","author":"K Rawat","year":"2023","unstructured":"Rawat K, Jakubzick CV (2023) Channeling antigens to CD8(+) T cells. Science 380(6651):1218\u20131219","journal-title":"Science"},{"issue":"86","key":"4046_CR57","doi-asserted-by":"publisher","first-page":"p. eadj9549","DOI":"10.1126\/sciimmunol.adj9549","volume":"8","author":"X Yin","year":"2023","unstructured":"Yin X, Eisenbarth SC (2023) Escape from the pore. Sci Immunol 8(86):eadj9549","journal-title":"Sci Immunol"},{"issue":"2","key":"4046_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"35","author":"N Zhang","year":"2011","unstructured":"Zhang N, Bevan MJ (2011) CD8(+) T cells: foot soldiers of the immune system. Immunity 35(2):161\u2013168","journal-title":"Immunity"},{"issue":"4","key":"4046_CR59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2559.2005.02305.x","volume":"48","author":"K Johrens","year":"2006","unstructured":"Johrens K et al (2006) Different T-bet expression patterns characterize particular reactive lymphoid tissue lesions. Histopathology 48(4):343\u2013352","journal-title":"Histopathology"},{"issue":"13","key":"4046_CR60","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1073\/pnas.1332767100","volume":"100","author":"G Lugo-Villarino","year":"2003","unstructured":"Lugo-Villarino G et al (2003) T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A 100(13):7749\u20137754","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5171","key":"4046_CR61","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","volume":"265","author":"D Kagi","year":"1994","unstructured":"Kagi D et al (1994) Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265(5171):528\u2013530","journal-title":"Science"},{"issue":"9","key":"4046_CR62","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5483\/BMBRep.2012.45.9.186","volume":"45","author":"EW Lee","year":"2012","unstructured":"Lee EW et al (2012) The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep 45(9):496\u2013508","journal-title":"BMB Rep"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04046-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:58:02Z","timestamp":1759305482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04046-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4046"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04046-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The University of Texas MD Anderson Cancer Center Institutional Review Board (PA14-0525; July 2014) and conducted in accord with the Declaration of Helsinki. The collection and evaluation of all protected patient health information was performed in a HIPAA compliant manner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}